SCHEMBL4848385

SCHEMBL4848385

CC(=O)c1ccccc1CN1CCOCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 5/20 0.59
ABCB1 P08183 1/20 0.52
CYP2C9 P11712 2/20 0.51
ALOX15 P16050 1/20 0.51
HSD17B10 Q99714 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7526646 0.87 CYP2A13 (0.58) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
SCHEMBL30640558 0.86 CYP2A13 (0.57) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
SCHEMBL230275 0.86 CYP2A13 (0.57) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
SCHEMBL4849151 0.85 MEN1 (0.54) ABCB1ALDH1A1KDM4EKMT2ALMNA
SCHEMBL2228234 0.84 KDM4E (0.58) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
SCHEMBL10533979 0.84 CYP2A13 (0.59) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
SCHEMBL11871949 0.84 MEN1 (0.56) ABCB1ALDH1A1KDM4EKMT2ALMNA
SCHEMBL5216465 0.84 HCRTR1 (0.60) CYP2A13CYP2C9ALOX15HSD17B10SMN1; SMN2
Hydrochloric Acid SCHEMBL11864597 0.83 MEN1 (0.55) ABCB1SMN1; SMN2RAB9AALDH1A1KDM4E
SCHEMBL1482081 0.83 HDAC3 (0.56) SMN1; SMN2ALDH1A1KDM4EKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20060052600-A1 Amino-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2006-03-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
EP-1506157-A2 AMINO-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-02-16 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed
WO-2003097575-A2 AMINO-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed